- Home
- DXCM vs TROW Comparison
DXCM vs TROW Comparison
Compare DXCM & TROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- TROW
- Stock Information
- Founded
- DXCM 1999
- TROW 1937
- Country
- DXCM United States
- TROW United States
- Employees
- DXCM N/A
- TROW N/A
- Industry
- DXCM Medical/Dental Instruments
- TROW Investment Bankers/Brokers/Service
- Sector
- DXCM Health Care
- TROW Finance
- Exchange
- DXCM Nasdaq
- TROW Nasdaq
- Market Cap
- DXCM 28.0B
- TROW 26.6B
- IPO Year
- DXCM 2005
- TROW N/A
- Fundamental
- Price
- DXCM $80.47
- TROW $121.71
- Analyst Decision
- DXCM Buy
- TROW Sell
- Analyst Count
- DXCM 17
- TROW 12
- Target Price
- DXCM $98.00
- TROW $115.33
- AVG Volume (30 Days)
- DXCM 3.6M
- TROW 1.3M
- Earning Date
- DXCM 02-06-2025
- TROW 02-06-2025
- Dividend Yield
- DXCM N/A
- TROW 4.08%
- EPS Growth
- DXCM 83.21
- TROW 30.16
- EPS
- DXCM 1.67
- TROW 9.13
- Revenue
- DXCM $3,954,000,000.00
- TROW $6,911,100,000.00
- Revenue This Year
- DXCM $13.10
- TROW $13.10
- Revenue Next Year
- DXCM $14.79
- TROW $5.41
- P/E Ratio
- DXCM $48.26
- TROW $13.33
- Revenue Growth
- DXCM 16.19
- TROW 8.96
- 52 Week Low
- DXCM $62.34
- TROW $98.36
- 52 Week High
- DXCM $142.00
- TROW $125.81
- Technical
- Relative Strength Index (RSI)
- DXCM 63.91
- TROW 55.78
- Support Level
- DXCM $77.33
- TROW $123.38
- Resistance Level
- DXCM $82.26
- TROW $125.81
- Average True Range (ATR)
- DXCM 2.38
- TROW 1.90
- MACD
- DXCM 0.07
- TROW -0.35
- Stochastic Oscillator
- DXCM 81.64
- TROW 54.04
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About TROW T. Rowe Price Group Inc.
T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load us and international stock, hybrid, bond, and money market funds. At the end of August 2024, the firm had $1.612 trillion in managed assets, composed of equity (51%), balanced (34%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a us-based asset manager, deriving less than 10% of its AUM from overseas.